{
}
In January, Saudi Arabia's Public Investment Fund (PIF) issued a US dollar bond, sold Thiqah Business Services for $907 million, and acquired a 23% stake in Saudi Re. The fund also invested $200 million in the SPDR Saudi bond ETF to enhance the Kingdom's debt market. PIF's activities in 2025 included acquiring Niantic’s gaming division for $3.5 billion and reaffirming its commitment to Newcastle United FC. The tourism sector saw a surge in private investment, reaching SR14.2 billion, with 40% from foreign investors, as the Kingdom aims to generate $80 billion by 2030 to diversify its economy. PIF ranked as the second most active sovereign investor globally in February, committing $3 billion across 22 deals, reflecting its strategic shift towards long-term resilience in sectors like healthcare and electric vehicles.
Artificial intelligence is set to revolutionize healthcare, with Barclays projecting a growth rate exceeding 30% annually through 2030. However, regulatory hurdles and uncertain reimbursement policies may hinder widespread adoption. Key players include UnitedHealth Group and Thermo Fisher Scientific, alongside high-risk firms like Tempus and Recursion Pharmaceuticals, as the industry navigates challenges in trust and implementation costs.
Saudi Arabia’s Public Investment Fund (PIF) ranked as the world’s second most active sovereign investor in February, committing $3 billion across three overseas deals. This surge reflects a strategic shift towards global opportunities, with PIF managing $925 billion in assets and focusing on sectors like healthcare and gaming. Notable moves include increased stakes in Lucid Motors and Amazon, alongside a $3.5 billion acquisition of Niantic’s gaming division.
The global Cell Line Development Market is projected to grow at a CAGR of 12.13% from 2024 to 2031, driven by increasing demand in drug discovery and biopharmaceutical production. Key players include Lonza Group AG, Thermo Fisher Scientific Inc, and GE Healthcare, with significant regional markets in North America, Europe, and Asia-Pacific. The report offers insights into market trends, challenges, and opportunities, utilizing both qualitative and quantitative research methods.
Deutsche Bank has adjusted its price target for Thermo Fisher Scientific to $615 from $630 while maintaining a Buy rating. The company specializes in laboratory and scientific equipment, with net sales primarily from laboratory equipment (73.9%), followed by scientific analysis equipment (16.3%) and diagnostics products (9.8%). Geographically, sales are led by North America (53.1%), followed by Europe (25.1%) and Asia/Pacific (18.4%).
Thermo Fisher Scientific experienced an 8.25% decrease in insider ownership, with executives selling 29,000 shares worth $15.86 million in the last three months. Institutional investors hold 89.23% of the stock, with State Street Corp and FMR LLC increasing their stakes significantly. UBS Group raised its price target for the stock to $715, indicating a potential upside of 19.23%.
Priya Pandey, a biotechnology graduate, excels in creating engaging content across various industries, including healthcare and technology. Coherent Market Insights offers comprehensive market intelligence and consulting services, providing detailed reports on sectors like food and beverages and pharmaceuticals, with insights into market dynamics and competitive strategies. The latest report on the Lateral Flow Assay Market forecasts trends and growth from 2024 to 2031, analyzing consumer behavior and regulatory factors while highlighting key players and emerging opportunities.
The global tuberculosis diagnostics market, valued at approximately $2.05 billion in 2023, is projected to grow to $3.6 billion by 2033, driven by advancements in nucleic acid testing and increasing healthcare investments. Key opportunities lie in smear microscopy, active tuberculosis detection, and hospital diagnostics, with significant growth expected in the Asia-Pacific and North America regions. Major players include Beckton, Dickinson and Company, Qiagen, and F. Hoffmann-La Roche, collectively holding a substantial market share.
The global clinical biomarkers market, valued at $25.02 billion in 2023, is projected to reach $47.25 billion by 2031, growing at a CAGR of 8.54%. This growth is driven by rising cancer cases and advancements in diagnostic technologies, despite challenges like high costs and reimbursement issues. Key players include Roche, Abbott, and Johnson & Johnson, with significant developments in biomarker testing for various diseases.
The global CRISPR and Cas gene market reached approximately $3.3 billion in 2023, growing at a CAGR of 20.38% since 2018. It is projected to expand to $8.8 billion by 2028 and $24.6 billion by 2033, driven by advancements in cancer therapeutics and gene therapy research. North America leads the market, accounting for 45.3% of the total value in 2023.
Thermo Fisher Scientific Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
saudi arabia's tourism sector attracts record investment amid shifting travel trends
United States Dollar
Regeneron Pharmaceuticals, Inc.
Amazon.com, Inc.
Thermo Fisher Scientific Inc.
SAU
Mohammed bin Salman Al Saud
Ahmed Al Khateeb
Show more
12:54 02.04.2025
AI in healthcare faces regulatory hurdles but shows strong investment potential
13:30 30.03.2025
saudi public investment fund ranks second in global sovereign investment activity
United States Dollar
British Pound Sterling
Regeneron Pharmaceuticals, Inc.
Amazon.com, Inc.
Thermo Fisher Scientific Inc.
KOR
SAU
GBR
CAN
Mohammed bin Salman Al Saud
Show more
14:12 25.03.2025
cell line development market projected to grow at 12.13 percent CAGR through 2031
Euro
United States Dollar
Thermo Fisher Scientific Inc.
Promega Corporation Corp.
Lonza Group AG
Corning Inc
GE HealthCare Technologies Inc.
NLD
FRA
ESP
MEX
GBR
ARE
ITA
IND
JPN
CAN
AUS
RUS
DEU
ZAF
KOR
SAU
BRA
USA
CHN
IDN
COL
ARG
Saikiran
Show more
19:14 22.03.2025
deutsche bank lowers price target for thermo fisher scientific to 615
13:15 06.03.2025
thermo fisher scientific sees insider selling and institutional investment shifts
20:43 01.02.2025
lateral flow assay market analysis trends and growth opportunities 2024 to 2031
United States Dollar
QuidelOrtho Corporation
Hologic Inc
Thermo Fisher Scientific Inc.
QIAGEN NV
Siemens AG
Abcam plc
PerkinElmer Inc
Danaher Corporation
Eiken Chemical Co., Ltd.
Becton, Dickinson and Company
Merck KGaA
Bio-Rad Laboratories Inc
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Biomerieux SA
FRA
ARG
NZL
CAN
TUR
SAU
ARE
USA
RUS
IND
AUS
ESP
GBR
SGP
BRA
IRN
CHN
DEU
MEX
ITA
JPN
Priya Pandey
Show more
09:06 10.01.2025
growth opportunities in the tuberculosis diagnostics market through 2033
Euro
United States Dollar
Bio-Techne Corporation
Thermo Fisher Scientific Inc.
Qiagen N.V.
Bio-Rad Laboratories, Inc.
PerkinElmer Inc
Becton, Dickinson and Company
BioMerieux SA
Abbott Laboratories
USA
Show more
10:21 06.01.2025
global clinical biomarkers market projected to reach 47 billion by 2031
Eurofins Scientific S.E. A
PerkinElmer Inc
Johnson & Johnson Services Inc.
Bio-Rad Laboratories, Inc.
Qiagen N.V.
Merck KGaA
Thermo Fisher Scientific Inc.
General Electric Co
Siemens Healthineers AG
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
USA
Show more
08:45 16.12.2024
global growth trends in the crispr and cas gene market to 2033
United States Dollar
Bayer AG
Bio-Rad Laboratories, Inc.
Pluristem Therapeutics Inc.
Genscript Biotech Corporation
AstraZeneca PLC
Qiagen N.V.
Hologic, Inc.
Cellectis S.A.
Takara Bio Inc.
Vertex Pharmaceuticals Inc
Thermo Fisher Scientific Inc.
Sigma-Aldrich Co. LLC
Regeneron Pharmaceuticals Inc
Editas Medicine Inc
IND
GBR
ESP
CAN
AUS
ITA
IDN
JPN
BRA
DEU
FRA
RUS
KOR
CHN
USA
Show more
15:27 13.12.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Industry Trends
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Private Equity Deals
Government Economic Policies
Supply Chain Management
Fintech Startups
Venture Capital Investments
Retail and Consumer Goods
Inflation and Monetary Impact
Workplace Trends
Energy Sector Developments
Finance Mergers & Acquisitions
Central Bank Actions
CEO Changes
Emerging Startups
Crypto Policies and Governance
Countries:
Companies:
Apple Inc.
NIO Inc.
Nikkei 225
Google Inc.
Nintendo Co., Ltd.
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
Eurasia Groupe SA
British International Investment plc
XPeng Inc.
Li Auto Inc.
Morgan Stanley
Taiwan Semiconductor Manufacturing Company Limited
VFS Global AG
LARGAN Precision Co.,Ltd
S&P/ASX 200
HANG SENG BANK
Delhivery Limited
Ecom Express Ltd.
Arazul Sequoia Capital FIM C Priv
Currencies:
United States Dollar
Indian Rupee
Euro
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
South Korean Won
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
Egyptian Pound
People: